JORDEN DAVID EMERSON
Insider CIK 1313516 · OPXA Acting Chief Financial Officer, Director · CMXI CEO/CFO, Director, 10% owner · PLXP Acting Chief Financial Officer, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AURX Nuo Therapeutics, Inc. | A Award | 2026-08-28 | 2026-08-28 | 7,984 | $1.09 | $8.7K | 2,070,000 | SEC↗ |
| AURX Nuo Therapeutics, Inc. | P Buy | 2026-08-28 | 2026-08-31 | 7,984 | $1.09 | $8.7K | 2,070,000 | SEC↗ |
| AURX Nuo Therapeutics, Inc. | A Award | 2026-08-28 | 2026-08-28 | 7,984 | $1.09 | $8.7K | 2,070,000 | SEC↗ |
| AURX Nuo Therapeutics, Inc. | P Buy | 2026-08-28 | 2026-08-31 | 7,984 | $1.09 | $8.7K | 2,070,000 | SEC↗ |
| AURX Nuo Therapeutics, Inc. | A Award | 2026-08-27 | 2026-08-28 | 789 | $1.07 | $844 | 2,062,016 | SEC↗ |
| AURX Nuo Therapeutics, Inc. | P Buy | 2026-08-27 | 2026-08-31 | 789 | $1.07 | $844 | 2,062,016 | SEC↗ |
| AURX Nuo Therapeutics, Inc. | A Award | 2026-08-27 | 2026-08-28 | 789 | $1.07 | $844 | 2,062,016 | SEC↗ |
| AURX Nuo Therapeutics, Inc. | P Buy | 2026-08-27 | 2026-08-31 | 789 | $1.07 | $844 | 2,062,016 | SEC↗ |
| AURX Nuo Therapeutics, Inc. | M Exercise deriv | 2026-06-30 | 2026-07-02 | 162,500 | — | $0 | 0 | SEC↗ |
| AURX Nuo Therapeutics, Inc. | M Exercise | 2026-06-30 | 2026-07-02 | 162,500 | $1.00 | $162.5K | 2,222,119 | SEC↗ |
| AURX Nuo Therapeutics, Inc. | F Tax w/h | 2026-06-30 | 2026-07-02 | 160,892 | $1.01 | $162.5K | 2,061,227 | SEC↗ |
| AURX Nuo Therapeutics, Inc. | A Award deriv | 2026-06-29 | 2026-07-02 | 125,000 | — | $0 | 125,000 | SEC↗ |
| AURX Nuo Therapeutics, Inc. | A Award | 2026-06-05 | 2026-06-05 | 13,245 | $1.10 | $14.6K | 2,085,000 | SEC↗ |
| AURX Nuo Therapeutics, Inc. | F Tax w/h | 2026-01-01 | 2026-01-05 | 25,381 | $1.97 | $50.0K | 2,046,374 | SEC↗ |
| AURX Nuo Therapeutics, Inc. | M Exercise | 2026-01-01 | 2026-01-05 | 125,000 | $0.40 | $50.0K | 2,071,755 | SEC↗ |
| AURX Nuo Therapeutics, Inc. | S Sale | 2025-11-28 | 2025-12-03 | 200,000 | $1.50 | $300.0K | 1,946,755 | SEC↗ |
| AURX Nuo Therapeutics, Inc. | M Exercise | 2025-08-01 | 2025-08-04 | 92,710 | $0.40 | $37.1K | 2,168,068 | SEC↗ |
| AURX Nuo Therapeutics, Inc. | M Exercise | 2025-08-01 | 2025-08-04 | 100,000 | $0.40 | $40.0K | 2,075,358 | SEC↗ |
| AURX Nuo Therapeutics, Inc. | F Tax w/h | 2025-08-01 | 2025-08-04 | 21,313 | $1.74 | $37.1K | 2,146,755 | SEC↗ |
| AURX Nuo Therapeutics, Inc. | S Sale | 2022-11-09 | 2022-11-14 | 20,000 | $1.50 | $30.0K | 2,010,858 | SEC↗ |
| AURX Nuo Therapeutics, Inc. | S Sale | 2022-11-09 | 2022-11-14 | 30,000 | $1.50 | $45.0K | 2,077,858 | SEC↗ |
| AURX Nuo Therapeutics, Inc. | S Sale | 2022-11-09 | 2022-11-14 | 27,000 | $1.50 | $40.5K | 2,050,858 | SEC↗ |
| AURX Nuo Therapeutics, Inc. | S Sale | 2022-11-09 | 2022-11-14 | 13,500 | $1.50 | $20.3K | 1,997,358 | SEC↗ |
| AURX Nuo Therapeutics, Inc. | S Sale | 2022-11-09 | 2022-11-14 | 30,000 | $1.50 | $45.0K | 2,107,858 | SEC↗ |
| AURX Nuo Therapeutics, Inc. | S Sale | 2022-11-09 | 2022-11-14 | 7,000 | $1.50 | $10.5K | 1,980,358 | SEC↗ |
| AURX Nuo Therapeutics, Inc. | S Sale | 2022-11-09 | 2022-11-14 | 5,000 | $1.50 | $7.5K | 1,975,358 | SEC↗ |
| AURX Nuo Therapeutics, Inc. | S Sale | 2022-11-09 | 2022-11-14 | 10,000 | $1.50 | $15.0K | 1,987,358 | SEC↗ |
| AURX Nuo Therapeutics, Inc. | S Sale | 2022-11-09 | 2022-11-14 | 20,000 | $1.50 | $30.0K | 2,030,858 | SEC↗ |
| AURX Nuo Therapeutics, Inc. | A Award | 2022-04-29 | 2022-05-02 | 10,532 | $1.00 | $10.5K | 2,137,858 | SEC↗ |
| AURX Nuo Therapeutics, Inc. | A Award deriv | 2022-03-04 | 2022-04-26 | 66,672 | — | $0 | 66,672 | SEC↗ |
| AURX Nuo Therapeutics, Inc. | A Award deriv | 2022-03-04 | 2022-04-26 | 125,000 | — | $0 | 125,000 | SEC↗ |
| AURX Nuo Therapeutics, Inc. | A Award deriv | 2019-01-01 | 2019-01-03 | 125,000 | — | $0 | 125,000 | SEC↗ |
| AURX Nuo Therapeutics, Inc. | M Exercise deriv | 2018-12-31 | 2026-01-05 | 125,000 | — | $0 | 0 | SEC↗ |
| AURX Nuo Therapeutics, Inc. | M Exercise deriv | 2018-08-09 | 2025-08-04 | 192,710 | — | $0 | 0 | SEC↗ |
| AURX Nuo Therapeutics, Inc. | A Award deriv | 2018-08-09 | 2018-08-13 | 192,710 | — | $0 | 192,710 | SEC↗ |
| AURX Nuo Therapeutics, Inc. | P Buy | 2017-08-10 | 2017-08-14 | 247,500 | $0.22 | $54.5K | 557,146 | SEC↗ |
| PLXP PLx Pharma Inc. | P Buy deriv | 2017-06-14 | 2017-06-16 | 32,727 | — | $0 | 32,727 | SEC↗ |
| PLXP PLx Pharma Inc. | P Buy | 2017-06-14 | 2017-06-16 | 32,727 | $6.88 | $225.2K | 151,913 | SEC↗ |
| PLXP PLx Pharma Inc. | A Award deriv | 2017-04-19 | 2017-04-20 | 33,753 | — | $0 | 33,753 | SEC↗ |
| PLXP PLx Pharma Inc. | A Award | 2017-04-19 | 2017-04-20 | 119,186 | — | $0 | 119,186 | SEC↗ |
| NONE Nuo Therapeutics, Inc. | A Award deriv | 2017-01-09 | 2017-01-11 | 162,500 | — | $0 | 162,500 | SEC↗ |
| NONE Nuo Therapeutics, Inc. | J Other | 2016-05-05 | 2016-07-29 | 54,049 | — | $0 | 191,549 | SEC↗ |
| NONE Nuo Therapeutics, Inc. | P Buy | 2016-05-05 | 2016-07-29 | 137,500 | $1.00 | $137.5K | 137,500 | SEC↗ |
| NONE Nuo Therapeutics, Inc. | J Other | 2016-05-05 | 2016-07-29 | 55,915 | — | $0 | 309,646 | SEC↗ |
| NONE Nuo Therapeutics, Inc. | J Other | 2016-05-05 | 2016-07-29 | 62,182 | — | $0 | 253,731 | SEC↗ |
| NONE Nuo Therapeutics, Inc. | J Other | 2016-05-05 | 2016-07-29 | 167 | — | $0 | 167 | SEC↗ |
| NUOT Nuo Therapeutics, Inc. | A Award deriv | 2015-07-09 | 2015-07-15 | 250,000 | — | $0 | 430,000 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | C Conversion deriv | 2013-09-24 | 2013-09-26 | 0 | — | $0 | 0 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | C Conversion | 2013-09-24 | 2013-09-26 | 61,912 | $1.91 | $118.3K | 293,456 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | A Award | 2013-06-30 | 2013-07-02 | 4,450 | $1.54 | $6.9K | 231,544 | SEC↗ |
| CMXI CYTOMEDIX INC | P Buy | 2013-05-21 | 2013-05-21 | 55,000 | $0.50 | $27.5K | 6,905,000 | SEC↗ |
| CMXI CYTOMEDIX INC | P Buy | 2013-05-17 | 2013-05-21 | 25,000 | $0.50 | $12.5K | 6,850,000 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | A Award deriv | 2013-04-29 | 2013-05-01 | 17,143 | — | $0 | 17,143 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | A Award deriv | 2013-04-29 | 2013-05-01 | 5,000 | — | $0 | 5,000 | SEC↗ |
| CMXI CYTOMEDIX INC | P Buy | 2013-04-19 | 2013-04-19 | 15,000 | $0.50 | $7.5K | 6,875,000 | SEC↗ |
| CMXI CYTOMEDIX INC | P Buy | 2013-04-18 | 2013-04-19 | 20,000 | $0.51 | $10.2K | 6,860,000 | SEC↗ |
| CMXI CYTOMEDIX INC | P Buy | 2013-04-17 | 2013-04-19 | 15,000 | $0.51 | $7.7K | 6,840,000 | SEC↗ |
| CMXI CYTOMEDIX INC | P Buy | 2013-04-09 | 2013-04-09 | 31,515 | $0.52 | $16.4K | 6,825,000 | SEC↗ |
| CMXI CYTOMEDIX INC | P Buy | 2013-04-08 | 2013-04-09 | 43,485 | $0.51 | $22.2K | 6,793,485 | SEC↗ |
| CMXI CYTOMEDIX INC | P Buy | 2013-02-27 | 2013-02-27 | 4,400 | $0.53 | $2.3K | 6,750,000 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | D To issuer deriv | 2013-02-26 | 2013-02-27 | 0 | — | $0 | 0 | SEC↗ |
| CMXI CYTOMEDIX INC | P Buy | 2013-02-26 | 2013-02-27 | 20,600 | $0.52 | $10.7K | 6,745,600 | SEC↗ |
| CMXI CYTOMEDIX INC | P Buy | 2013-02-22 | 2013-02-22 | 20,000 | $0.53 | $10.6K | 6,725,000 | SEC↗ |
| CMXI CYTOMEDIX INC | P Buy | 2013-02-21 | 2013-02-22 | 30,000 | $0.53 | $15.9K | 6,705,000 | SEC↗ |
| CMXI CYTOMEDIX INC | P Buy deriv | 2013-02-19 | 2013-02-21 | 114,286 | — | $0 | 620,110 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | A Award deriv | 2013-01-29 | 2013-01-31 | 5,278 | — | $0 | 5,278 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | A Award deriv | 2013-01-23 | 2013-01-24 | 37,500 | — | $0 | 77,034 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | A Award deriv | 2013-01-23 | 2013-01-24 | 0 | — | $0 | 37,500 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | A Award | 2012-12-31 | 2013-01-24 | 4,595 | $1.33 | $6.1K | 227,094 | SEC↗ |
| CMXI CYTOMEDIX INC | P Buy | 2012-09-14 | 2012-09-14 | 25,000 | $0.89 | $22.3K | 6,675,000 | SEC↗ |
| CMXI CYTOMEDIX INC | P Buy | 2012-09-11 | 2012-09-12 | 8,333 | $0.95 | $7.9K | 6,650,000 | SEC↗ |
| CMXI CYTOMEDIX INC | X Exercise deriv | 2012-08-29 | 2012-08-31 | 16,667 | — | $0 | 505,824 | SEC↗ |
| CMXI CYTOMEDIX INC | X Exercise | 2012-08-29 | 2012-08-31 | 16,667 | $1.00 | $16.7K | 6,641,667 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | A Award deriv | 2012-08-15 | 2012-08-16 | 75,000 | — | $0 | 75,000 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | A Award deriv | 2012-07-25 | 2012-07-27 | 107,813 | — | $0 | 1,150 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | A Award deriv | 2012-07-25 | 2012-07-27 | 0 | — | $0 | 107,813 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | A Award deriv | 2012-03-01 | 2012-03-05 | 10,000 | — | $0 | 10,000 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | A Award deriv | 2012-03-01 | 2012-03-05 | 20,600 | — | $0 | 20,600 | SEC↗ |
| CMXI CYTOMEDIX INC | X Exercise deriv | 2012-02-15 | 2012-02-15 | 200,000 | — | $0 | 701,065 | SEC↗ |
| CMXI CYTOMEDIX INC | X Exercise deriv | 2012-02-15 | 2012-02-15 | 178,571 | — | $0 | 522,494 | SEC↗ |
| CMXI CYTOMEDIX INC | X Exercise | 2012-02-15 | 2012-02-15 | 178,571 | $0.50 | $89.3K | 6,625,000 | SEC↗ |
| CMXI CYTOMEDIX INC | X Exercise | 2012-02-15 | 2012-02-15 | 200,000 | $0.54 | $108.0K | 6,446,429 | SEC↗ |
| CMXI CYTOMEDIX INC | S Sale | 2012-02-15 | 2012-02-15 | 76,313 | $1.15 | $87.8K | 6,246,429 | SEC↗ |
| CMXI CYTOMEDIX INC | S Sale | 2012-02-14 | 2012-02-15 | 27,000 | $1.20 | $32.4K | 6,322,742 | SEC↗ |
| CMXI CYTOMEDIX INC | S Sale | 2012-02-13 | 2012-02-15 | 39,775 | $1.25 | $49.7K | 6,349,742 | SEC↗ |
| CMXI CYTOMEDIX INC | J Other | 2012-02-08 | 2012-02-10 | 8,000 | — | $0 | 6,389,517 | SEC↗ |
| CMXI CYTOMEDIX INC | C Conversion | 2012-02-08 | 2012-02-10 | 143,370 | — | $0 | 6,381,517 | SEC↗ |
| CMXI CYTOMEDIX INC | J Other | 2012-01-17 | 2012-01-30 | 1,854 | — | $0 | 6,238,147 | SEC↗ |